Blockbuster merger between two drug giants imminent
US-based Pfizer in talks to buy Dublin based Allergan for as much as $380 a share
A mega merger between Pfizer and Allergan could come as early as Monday - valuing the Irish Botox-maker as high as $150bn.
US based Pfizer is understood to be in advanced talks to buy Dublin-domiciled Allergan for as much as $380 a share.
The proposed deal, still under negotiation, would probably see Pfizer redomicile in Ireland, where Allergan is registered and corporation taxes are much lower.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures